Coagulant recovery from water treatment residuals: a review of applicable technologies

Conventional water treatment consumes large quantities of coagulant and produces even greater volumes of sludge. Coagulant recovery (CR) presents an opportunity to reduce both the sludge quantities and the costs they incur, by regenerating and purifying coagulant before reuse. Recovery and purification must satisfy stringent potable regulations for harmful contaminants, while remaining competitive with commercial coagulants. These challenges have restricted uptake and lead research towards lower-gain, lower-risk alternatives. This review documents the context in which CR must be considered, before comparing the relative efficacies and bottlenecks of potential technologies, expediting identification of the major knowledge gaps and future research requirements

Fate and impact of organics in an immersed membrane bioreactor applied to brine denitrification and ion exchange regeneration

The application of membrane bioreactors (MBRs) to brine denitrification for ion exchange regeneration has been studied. The developed culture was capable of complete brine denitrification at 50 gNaCl.l−1. Denitrification reduced to c.60% and c.70% when salinity was respectively increased to 75 and 100 g.l−1, presumed to be due to reduced growth rate and the low imposed solids retention time (10 days). Polysaccharide secretion was not induced by stressed cells following salt shocking, implying that cell lysis did not occur. Fouling propensity, monitored by critical flux, was steady at 12–15 l.m−2.h−1 during salinity shocking and after brine recirculation, indicating that the system was stable following perturbation. Low molecular weight polysaccharide physically adsorbed onto the nitrate selective anion exchange resin during regeneration reducing exchange capacity by c.6.5% when operating up to complete exhaustion. However, based on a breakthrough threshold of 10 mgNO3−-N.l−1 the exchange capacity was comparative to that determined when using freshly produced brine for regeneration. It was concluded that a denitrification MBR was an appropriate technology for IEX spent brine reco

The status of industrial and municipal effluent treatment with membrane bioreactor technology

The status of MBR technology has been scrutinised with reference to (a) available commercial technologies and their characteristics, (b) key design and performance parameters of existing full-scale installations, and (c) practitioner perception. The key design and operating parameters of flux and COD removal were considered with reference to 100 installations, 40 based on municipal and 60 on industrial wastewater treatment. The perception of practitioners was appraised through a conventional survey, with 186 respondents. A review of the commercial products revealed polyvinylidene difluoride (PVDF) to be the most prevalent membrane material, accounting for almost half of all products, and provided both in flat sheet (FS) and hollow fibre (HF) configurations. Polyethylsulphone (PES) and polyolefinic membranes (polyethylene, PE and polypropylene, PP) were also found to be available in FS and HF configurations respectively. Almost all products had a nominal membrane pore size between 0.03 and 0.4 μm. Design fluxes in L m−2 h−1 (LMH) for municipal wastewater treatment were predominantly in the 15–25 LMH range, 18.5 ± 4.8 LMH on average, for the average daily flow (ADF), and in the 20–30 LMH range, 26.0 ± 6.6 LMH on average, for peak daily flow (PDF). Fluxes were lower, and dependent on both process configuration and effluent quality, for industrial effluents; the most challenging effluents (landfill leachate) were associated with the lowest fluxes. As expected, treatment capability related roughly to the feedwater BOD/COD ratio, with more than 90% COD removal achieved for food and beverage effluents (for which BOD/COD ratios were largely above 0.5) – comparable with municipal wastewater treatment. Respondents to the survey, around 85% of whom were practitioners, identified pre-treatment (screening) as presenting the greatest technical challenge to MBR operation

Membrane technology costs and me

A reflection of the place cost analysis holds in membrane process technology research and development is provided. The review encompassed two membrane processes and applications: (a) reverse osmosis (RO) for seawater desalination, and (b) membrane bioreactor (MBR) technology for wastewater treatment. The cost analysis undertaken extended to (i) the determination of operating expenditure (OPEX) trends using simple analytical expressions, (ii) the subsequent estimation of the sensitivity of OPEX to individual system parameters, and (iii) published data on CAPEX for individual full-scale installations or from cost analyses. An appraisal of the peer-reviewed literature through a survey of a leading scientific database was also carried out. This bibliometric analysis was based on authors’ keywords; it aimed to establish the profile of process cost for each of the two applications when compared with other popular research topics. The OPEX analysis, ostensibly through a consideration of specific energy demand in kWh per m3 permeate, revealed it to relate primarily to hydrodynamics in the case of RO, and to both membrane fouling and air scouring for MBRs. The bibliometric analysis of research trends revealed a marked difference in emphasis on cost aspects between the two research areas, with the focus on cost specifically being 16 times greater for RO desalination of seawater than MBR treatment of wastewater. MBR research appears to be dominated by fouling and foulant characterisation, making up almost a quarter of all studies, notwithstanding evidence from practitioners that other process parameters are as important in determining MBR process OPEX and operability

Investigating the significance of coagulation kinetics on maintaining membrane permeability in an MBR following reactive coagulant dosing

In this study, the impact of kinetically controlled floc growth on sustaining membrane permeability following reactive coagulant dosing was determined using a model particle system. Floc formation was indicated to comprise of two stages following coagulant addition: (i) an initial destabilisation phase which encouraged complexation of protein and polysaccharide; and (ii) entrapment of the coarse model particles (3 µm Firefli™ microspheres) in the polymeric complex during the floc growth phase. Floc growth was characterised by an expected time lag as with conventional flocculation systems and biopolymer aggregation was kinetically favoured. When coagulant was dosed during the filtration cycle, the intermediate biopolymer aggregates (comprised of protein and polysaccharide) were preferentially transported toward the membrane increasing fouling. However, when coagulant was dosed at the onset of filtration, membrane fouling was constrained. It is asserted that by dosing at the onset of filtration: (i) early development of biopolymer aggregation is initiated which inhibits transport of the individual biopolymers to the membrane; and (ii) by dosing coagulant in the absence of a developed polarised layer, formation of biopolymer complexes local to the membrane is obviated. However, when dosing coagulant at the onset of filtration, only limited floc growth occurred which can be explained by the low applied wall shear rate and the absence of a ‘polarised’ region which ostensibly promoted floc growth when coagulant was dosed mid-filtration. Based on results from the model particle system studied, it is proposed that reactive coagulant dosing is best undertaken when: (i) filtration is stopped; (ii) modest shear is applied within the bioreactor to promote coagulant dispersion; and (iii) sufficient contact time is allowed to promote floc growth before commencement of filtration

THM and HAA formation from NOM in raw and treated surface waters

The disinfection by-product (DBP) formation potential (FP) of natural organic matter (NOM) in surface water sources has been studied with reference to the key water quality determinants (WQDs) of UV absorption (UV254), colour, and dissolved organic carbon (DOC) concentration. The data set used encompassed raw and treated water sampled over a 30-month period from 30 water treatment works (WTWs) across Scotland, all employing conventional clarification. Both trihalomethane (THM) and haloacetic acid (HAA) FPs were considered. In addition to the standard bulk WQDs, the DOC content was fractionated and analysed for the hydrophobic (HPO) and hydrophilic (HPI) fractions. Results were quantified in terms of the yield (dDBPFP/dWQD) and the linear regression coefficient R2 of the yield trend. The NOM in the raw waters was found to comprise 30–84% (average 66%) of the more reactive HPO material, with this proportion falling to 18–63% (average 50%) in the treated water. Results suggested UV254 to be as good an indicator of DBPFP as DOC or HPO for the raw waters, with R2 values ranging from 0.79 to 0.82 for THMs and from 0.71 to 0.73 for HAAs for these three determinants. For treated waters the corresponding values were significantly lower at 0.52–0.67 and 0.46–0.47 respectively, reflecting the lower HPO concentration and thus UV254 absorption and commensurately reduced precision due to the limit of detection of the analytical instrument. It is concluded that fractionation offers little benefit in attempting to discern or predict chlorinated carbonaceous DBP yield for the waters across the geographical region studied. UV254 offered an adequate estimate of DBPFP based on a mean yield of ∼2600 and ∼2800 μg per cm−1 absorbance for THMFP for the raw and treated waters respectively and ∼3800 and2900 μg cm−1 for HAAFP, albeit with reduced precision for the treated waters

Pilot-scale spiral wound membrane assessment for THM precursor rejection from upland waters

The outcomes of a pilot-scale study of the rejection of trihalomethanes (THMs) precursors by commercial ultrafiltration/nanofiltration (UF/NF) spiral-wound membrane elements are presented based on a single surface water source in Scotland. The study revealed the expected trend of increased flux and permeability with increasing pore size for the UF membranes; the NF membranes provided similar fluxes despite the lower nominal pore size. The dissolved organic carbon (DOC) passage decreased with decreasing molecular weight cut-off, with a less than one-third the passage recorded for the NF membranes than for the UF ones. The yield (weight % total THMs per DOC) varied between 2.5% and 8% across all membranes tested, in reasonable agreement with the literature, with the aromatic polyamide membrane providing both the lowest yield and lowest DOC passage. The proportion of the hydrophobic (HPO) fraction removed was found to increase with decreasing membrane selectivity (increasing pore size), and THM generation correlated closely (R2 = 0.98) with the permeate HPO fractional concentration

Acidified and ultrafiltered recovered coagulants from water treatment works sludge for removal of phosphorus from wastewater

This study used a range of treated water treatment works sludge options for the removal of phosphorus (P) from primary wastewater. These options included the application of ultrafiltration for recovery of the coagulant from the sludge. The treatment performance and whole life cost (WLC) of the various recovered coagulant (RC) configurations have been considered in relation to fresh ferric sulphate (FFS). Pre-treatment of the sludge with acid followed by removal of organic and particulate contaminants using a 2kD ultrafiltration membrane resulted in a reusable coagulant that closely matched the performance FFS. Unacidified RC showed 53% of the phosphorus removal efficiency of FFS, at a dose of 20 mg/L as Fe and a contact time of 90 min. A longer contact time of 8 h improved performance to 85% of FFS. P removal at the shorter contact time improved to 88% relative to FFS by pre-acidifying the sludge to pH 2, using an acid molar ratio of 5.2:1 mol H+:Fe. Analysis of the removal of P showed that rapid phosphate precipitation accounted for >65% of removal with FFS. However, for the acidified RC a slower adsorption mechanism dominated; this was accelerated at a lower pH. A cost-benefit analysis showed that relative to dosing FFS and disposing waterworks sludge to land, the 20 year WLC was halved by transporting acidified or unacidified sludge up to 80 km for reuse in wastewater treatment. A maximum inter-site distance was determined to be 240 km above the current disposal route at current prices. Further savings could be made if longer contact times were available to allow greater P removal with unacidified RC

Reuse of recovered coagulants in water treatment: An investigation on the effect coagulant purity has on treatment performance

Coagulant recovery offers many potential benefits to water treatment, by reducing chemical demand and waste production. The key obstacle to successful implementation is achieving the same levels of treatment quality and process economics as commercial coagulants. This study has evaluated the selectivity of pressure-filtration in the role of a low-cost coagulant recovery technology from waterworks sludge. The treatment performance of the purified recovered coagulant was directly compared to fresh and raw recovered coagulants. DOC and turbidity removal by recovered coagulants was close to that of commercial coagulants, indicating that coagulant can be successfully recovered and regenerated by acidifying waterworks sludge. However, performance was less consistent, with a much narrower optimum charge neutralisation window and 10–30% worse removal performance under optimum conditions. This inferior performance was particularly evident for recovered ferric coagulants. The impact of this was confirmed by measuring THM formation potential and residual metals concentrations, showing 30–300% higher THMFPs when recovered coagulants were used. This study confirms that pressure-filtration can be operated on an economically viable basis, in terms of mass flux and fouling. However, the selectivity currently falls short of the purity required for potable treatment, due to incomplete rejection of sludge contaminants

Coagulant recovery and reuse for drinking water treatment

Coagulant recovery and reuse from waterworks sludge has the potential to significantly reduce waste disposal and chemicals usage for water treatment. Drinking water regulations demand purification of recovered coagulant before they can be safely reused, due to the risk of disinfection by-product precursors being recovered from waterworks sludge alongside coagulant metals. While several full-scale separation technologies have proven effective for coagulant purification, none have matched virgin coagulant treatment performance. This study examines the individual and successive separation performance of several novel and existing ferric coagulant recovery purification technologies to attain virgin coagulant purity levels. The new suggested approach of alkali extraction of dissolved organic compounds (DOC) from waterworks sludge prior to acidic solubilisation of ferric coagulants provided the same 14:1 selectivity ratio (874 mg/L Fe vs. 61 mg/L DOC) to the more established size separation using ultrafiltration (1285 mg/L Fe vs. 91 mg/L DOC). Cation exchange Donnan membranes were also examined: while highly selective (2555 mg/L Fe vs. 29 mg/L DOC, 88:1 selectivity), the low pH of the recovered ferric solution impaired subsequent treatment performance. The application of powdered activated carbon (PAC) to ultrafiltration or alkali pre-treated sludge, dosed at 80 mg/mg DOC, reduced recovered ferric DOC contamination to <1 mg/L but in practice, this option would incur significant costs. The treatment performance of the purified recovered coagulants was compared to that of virgin reagent with reference to key water quality parameters. Several PAC-polished recovered coagulants provided the same or improved DOC and turbidity removal as virgin coagulant, as well as demonstrating the potential to reduce disinfection byproducts and regulated metals to levels comparable to that attained from virgin material